Literature DB >> 29066646

Recurrence of immature ovarian teratoma as malignant follicular carcinoma with liver and peritoneal metastasis 22 years after completion of initial treatment.

Nicholas Brian Shannon1, Norman Hok Ling Chan2, Melissa Ching Ching Teo3.   

Abstract

Growing tumour syndrome (GTS) is a rare event in which germ cell tumours treated with chemotherapy undergo maturation, acquire resistance to chemotherapy and regrow. The optimum treatment strategy is complete surgical excision. We report on a case of GTS with malignant metastases to the liver presenting 22 years after completion of treatment for immature teratoma, successfully managed with surgical resection alone. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  gynecological cancer; oncology

Mesh:

Year:  2017        PMID: 29066646      PMCID: PMC5665351          DOI: 10.1136/bcr-2017-219665

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Growing teratoma syndrome: clinical and radiographic characteristics.

Authors:  Dennis J Lee; Hooman Djaladat; Nicholas N Tadros; Mehran Movassaghi; Tapas Tejura; Vinay Duddalwar; Siamak Daneshmand
Journal:  Int J Urol       Date:  2014-04-21       Impact factor: 3.369

2.  Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased.

Authors:  K S Tonkin; G J Rustin; B Wignall; F Paradinas; M Bennett
Journal:  Eur J Cancer Clin Oncol       Date:  1989-12

3.  The growing teratoma syndrome.

Authors:  G M Jeffery; J M Theaker; A H Lee; R M Blaquiere; C J Smart; G M Mead
Journal:  Br J Urol       Date:  1991-02

4.  The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients.

Authors:  F André; K Fizazi; S Culine; J Droz; P Taupin; C Lhommé; M Terrier-Lacombe; C Théodore
Journal:  Eur J Cancer       Date:  2000-07       Impact factor: 9.162

5.  Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.

Authors:  Philippe E Spiess; Wassim Kassouf; Gordon A Brown; Ashish M Kamat; Ping Liu; Jose A Gomez; Shi-Ming Tu; Nizar M Tannir; Louis L Pisters
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

6.  The growing teratoma syndrome.

Authors:  C J Logothetis; M L Samuels; A Trindade; D E Johnson
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

Review 7.  Growing teratoma syndrome.

Authors:  H B Tongaonkar; V H Deshmane; A V Dalal; J N Kulkarni; M R Kamat
Journal:  J Surg Oncol       Date:  1994-01       Impact factor: 3.454

8.  Late recurrences in long-term survivors of germ cell neoplasms.

Authors:  M J DeLeo; F A Greco; J D Hainsworth; D H Johnson
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

9.  Unusual liver locations of growing teratoma syndrome in ovarian malignant germ cell tumors.

Authors:  Domenica Lorusso; Paola Malaguti; Ilaria Nausica Trivellizzi; Giovanni Scambia
Journal:  Gynecol Oncol Case Rep       Date:  2011-08-08

10.  Growing Teratoma Syndrome Secondary to Ovarian Giant Immature Teratoma in an Adolescent Girl: A Case Report and Literature Review.

Authors:  Song Li; Zhenzhen Liu; Chengyong Dong; Fei Long; Qinlong Liu; Deguang Sun; Zhenming Gao; Liming Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  2 in total

1.  Rare primary mature teratoma of the liver: A case report.

Authors:  Yury A Kovalenko; Yury O Zharikov; Yana V Kiseleva; Anton B Goncharov; Tatyana V Shevchenko; Beslan N Gurmikov; Dmitry V Kalinin; Alexey V Zhao
Journal:  World J Hepatol       Date:  2021-12-27

2.  Pelvic masses after surgery for immature ovarian teratoma: A 10-year experience of Western China.

Authors:  Sixia Xie; Xibiao Jia; Tingting Li; Yuanyuan Xu; Weiwei Wu; Yichao Qiu; Shuang Yuan; Xue Peng; Hongjing Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.